|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense), net: | ||
| Other income, net | ||
| Net loss attributable to common stockholders-basic | ||
| Net loss attributable to common stockholders- diluted | ||
| Weighted-average common stock outstanding-basic | ||
| Weighted-average common stock outstanding- diluted | ||
| Net loss per share attributable to common stockholders-basic | ||
| Net loss per share attributable to common stockholders- diluted | ||
| Net loss | ||
| Unrealized loss on marketable securities | ||
| Total comprehensive loss |
Loading...
